Cargando…
Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science China Press. Published by Elsevier B.V. and Science China Press.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837489/ https://www.ncbi.nlm.nih.gov/pubmed/35186363 http://dx.doi.org/10.1016/j.scib.2022.02.002 |
| _version_ | 1784649920701005824 |
|---|---|
| author | Lin, Xian Ke, Xianliang Jian, Xiaoqin Xia, Lin Yang, Yang Zhang, Tianying Xiong, Hualong Zhao, Binghai Liu, Wen Chen, Quanjiao Tang, Chong |
| author_facet | Lin, Xian Ke, Xianliang Jian, Xiaoqin Xia, Lin Yang, Yang Zhang, Tianying Xiong, Hualong Zhao, Binghai Liu, Wen Chen, Quanjiao Tang, Chong |
| author_sort | Lin, Xian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8837489 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Science China Press. Published by Elsevier B.V. and Science China Press. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88374892022-02-14 Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19 Lin, Xian Ke, Xianliang Jian, Xiaoqin Xia, Lin Yang, Yang Zhang, Tianying Xiong, Hualong Zhao, Binghai Liu, Wen Chen, Quanjiao Tang, Chong Sci Bull (Beijing) Short Communication Science China Press. Published by Elsevier B.V. and Science China Press. 2022-05-30 2022-02-12 /pmc/articles/PMC8837489/ /pubmed/35186363 http://dx.doi.org/10.1016/j.scib.2022.02.002 Text en © 2022 Science China Press. Published by Elsevier B.V. and Science China Press. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Short Communication Lin, Xian Ke, Xianliang Jian, Xiaoqin Xia, Lin Yang, Yang Zhang, Tianying Xiong, Hualong Zhao, Binghai Liu, Wen Chen, Quanjiao Tang, Chong Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19 |
| title | Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19 |
| title_full | Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19 |
| title_fullStr | Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19 |
| title_full_unstemmed | Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19 |
| title_short | Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19 |
| title_sort | azacytidine targeting sars-cov-2 viral rna as a potential treatment for covid-19 |
| topic | Short Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837489/ https://www.ncbi.nlm.nih.gov/pubmed/35186363 http://dx.doi.org/10.1016/j.scib.2022.02.002 |
| work_keys_str_mv | AT linxian azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT kexianliang azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT jianxiaoqin azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT xialin azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT yangyang azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT zhangtianying azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT xionghualong azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT zhaobinghai azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT liuwen azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT chenquanjiao azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 AT tangchong azacytidinetargetingsarscov2viralrnaasapotentialtreatmentforcovid19 |